Switching ST udy of Kidney TRansplant PA tients with Tremor to LCP ‐TacrO ( STRATO ): an open‐label, multicenter, prospective phase 3b study

Author:

Langone Anthony1,Steinberg Steven M.2,Gedaly Roberto3,Chan Laurence K.4,Shah Tariq5,Sethi Kapil D.6,Nigro Vincenza7,Morgan John C.6,Formica Richard N.,Barr Yousri M.,Brennan Daniel C.,El‐Amm Jose‐Marie Albert,Kozlowski Tomasz,Matas Arthur Jeremy,West‐Thielke Patricia M.,Kistler Kristin,

Affiliation:

1. Vanderbilt University Medical Center Nashville TN USA

2. California Institute of Renal Research San Diego CA USA

3. University of Kentucky Medical Center Lexington KY USA

4. University of Colorado Denver Aurora CO USA

5. Transplant Research Institute Los Angeles CA USA

6. Georgia Regents University Augusta GA USA

7. Veloxis Pharmaceuticals Edison NJ USA

Funder

Veloxis Pharmaceuticals

Publisher

Wiley

Subject

Transplantation

Reference29 articles.

1. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients;Webster AC;Cochrane Database Syst Rev,2005

2. Draft Guidance on Tacrolimus. Available at:http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM181006.pdf[Last accessed 2 July 2014].

3. Adverse Effects of Tacrolimus in Renal Transplant Patients from Living Donors

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3